<--- Back to Details
First PageDocument Content
Center for Devices and Radiological Health / Office of Regulatory Affairs / Center for Biologics Evaluation and Research / Title 21 of the Code of Federal Regulations / Center for Drug Evaluation and Research / Regulatory affairs / Medical device / Biologic / Good Clinical Data Management Practice / Food and Drug Administration / Medicine / Health
Center for Devices and Radiological Health
Office of Regulatory Affairs
Center for Biologics Evaluation and Research
Title 21 of the Code of Federal Regulations
Center for Drug Evaluation and Research
Regulatory affairs
Medical device
Biologic
Good Clinical Data Management Practice
Food and Drug Administration
Medicine
Health

Staff Manual Guide[removed]

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 23,61 KB

Share Document on Facebook

Similar Documents

Jeffrey Shuren, M.D., J.D. Director Center for Devices and Radiological Health Food and Drug AdministrationNew Hampshire Avenue Silver Spring, MD

DocID: 1tLOR - View Document

Digital Health Innovation Action Plan  Introduction FDA’s Center for Devices and Radiological Health (CDRH) puts patients at the forefront of our vision—we are driven by timely patient access to high-quality, s

DocID: 1ttzz - View Document

Post-doctoral fellow position #2 – Research Focus Nanotechnology/nanotoxicology - Safety of engineered nanomaterials The Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryl

DocID: 1sM2j - View Document

Sunlamps: Regulatory Issues W. Howard Cyr, Ph.D. Office of Science and Technology, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD USA For distribution at the following meetings:

DocID: 1srEV - View Document

Food and Drug Administration / Health / Food law / Pharmaceuticals policy / Personal life / Pharmaceutical industry / Healthcare quality / Federal Food /  Drug /  and Cosmetic Act / Medical device / Validation / Center for Devices and Radiological Health / RNA-Seq

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

DocID: 1rmMY - View Document